Sequentify

About Sequentify

Sequentify is a startup that operates in the field of genomic sequencing. The company provides a solution that simplifies the process of Next-Generation Sequencing (NGS), a method used to determine the precise order of nucleotides within a DNA molecule. Sequentify's primary product is the InfiniSeq Kit, a tool that makes the sequencing process easier and more cost-effective.

The company's clients are primarily in the healthcare and scientific research sectors, where there is a growing demand for sequencing. The InfiniSeq technology is platform-agnostic, meaning it can be used with any sequencing hardware. This flexibility makes it a valuable tool for labs and research institutions that may use different sequencing platforms.

Sequentify's business model is based on selling its InfiniSeq Kits and providing a bioinformatics pipeline, a process that transforms raw genomic data into understandable information. The company's solution is unique because it addresses the most expensive part of the NGS process: library preparation. By making this step more affordable, Sequentify is helping to reduce the overall cost of sequencing, making it more accessible for routine tests in the healthcare sector and beyond.

In summary, Sequentify is a promising startup that is making genomic sequencing more affordable and accessible. Its innovative solution has the potential to enable genomic diagnostics and therapeutics at a population-wide scale, paving the way for a future where NGS is a routine test in the healthcare sector.